Ledger.Open graph →
SEC Form D · filed April 11, 2014

Cellular Biomedicine Group, Inc

Offering
$7.0M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Wei (William) Cao · Palo Alto, CAExec · DirectorNadir A. Patel · Cupertino, CADirectorJeff Auerbach · Palo Alto, CADirectorAndrew Chan · Palo Alto, CAExecWen Tao (Steve) Liu · Palo Alto, CADirectorTerry A. Belmont · Palo Alto, CADirectorBrian W. Throckmorton · London, OHDirectorTerry A. Belmont · Cupertino, CADirectorGerardus A. Hoogland · Palo Alto, CADirectorNadir A. Patel · Palo Alto, CADirectorDavid E. Snyder · Newport Beach, CAExecBizou (Tony) Liu · Palo Alto, CADirectorRobert W. Antablin · New York, NYDirectorStacie K. Yamane · Newport Beach, CADirectorDavid Bolocan · Palo Alto, CADirectorJainping Dai · Palo Alto, CADirectorPeter M. Bren · Newport Beach, CAExec · DirectorKeith Wong · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗